FORTIS.NS Stock Analysis
FO
Neutral
Based on Eyestock quantitative analysis, FORTIS.NS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Market cap $B
1.115
Dividend yield
0.20 %
Shares outstanding
754.96 B
Fortis Healthcare Ltd. engages in the provision of healthcare delivery services through its subsidiaries. The company is headquartered in Gurgaon, Haryana and currently employs 2,975 full-time employees. The company went IPO on 2007-05-09. The firm is primarily engaged in the business of healthcare services. The firm operates through healthcare services segment. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. The company manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics, and day care specialty facilities. The company has approximately 27 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. The company operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Health staff Limited, and Fortis Asia Healthcare Pte. Ltd, among others.